ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Bristol-Myers Squibb Co.

Bristol-Myers Squibb Co. (BMYB34)

360.47
-7.90
( -2.14% )
Updated: 11:54:16

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
360.47
Bid
359.51
Ask
360.52
Volume
79
359.00 Day's Range 361.18
203.10 52 Week Range 369.03
Market Cap
Previous Close
368.37
Open
359.00
Last Trade
1
@
360.47
Last Trade Time
11:54:16
Financial Volume
R$ 28,486
VWAP
360.582
Average Volume (3m)
236
Shares Outstanding
2,028,177,000
Dividend Yield
4.15%
PE Ratio
-14.01
Earnings Per Share (EPS)
-4.41
Revenue
48.3B
Net Profit
-8.95B

About Bristol-Myers Squibb Co.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Bristol-Myers Squibb Co. is listed in the Pharmaceutical Preparations sector of the Brazil Bovespa Exchange with ticker BMYB34. The last closing price for Bristol-Myers Squibb was R$368.37. Over the last year, Bristol-Myers Squibb shares have traded in a share price range of R$ 203.10 to R$ 369.03.

Bristol-Myers Squibb currently has 2,028,177,000 shares outstanding. The market capitalization of Bristol-Myers Squibb is R$747.12 billion. Bristol-Myers Squibb has a price to earnings ratio (PE ratio) of -14.01.

BMYB34 Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
17.642.16534875152352.83369.03346.1998360.75788396DR
436.6611.321453939323.81369.03308.49512323.94285598DR
128.172.31904626739352.3369.03308.49236326.96265676DR
2688.5132.5452272393271.96369.03271.96207333.57742597DR
5289.6633.1080831579270.81369.03203.1473248.81330431DR
15611.763.37242981274348.71431.76203.1417296.90203825DR
26095.1535.8623548922265.32431.76203.1507316.66589414DR

BMYB34 - Frequently Asked Questions (FAQ)

What is the current Bristol-Myers Squibb share price?
The current share price of Bristol-Myers Squibb is R$ 360.47
How many Bristol-Myers Squibb shares are in issue?
Bristol-Myers Squibb has 2,028,177,000 shares in issue
What is the market cap of Bristol-Myers Squibb?
The market capitalisation of Bristol-Myers Squibb is BRL 747.12B
What is the 1 year trading range for Bristol-Myers Squibb share price?
Bristol-Myers Squibb has traded in the range of R$ 203.10 to R$ 369.03 during the past year
What is the PE ratio of Bristol-Myers Squibb?
The price to earnings ratio of Bristol-Myers Squibb is -14.01
What is the cash to sales ratio of Bristol-Myers Squibb?
The cash to sales ratio of Bristol-Myers Squibb is 2.6
What is the reporting currency for Bristol-Myers Squibb?
Bristol-Myers Squibb reports financial results in USD
What is the latest annual turnover for Bristol-Myers Squibb?
The latest annual turnover of Bristol-Myers Squibb is USD 48.3B
What is the latest annual profit for Bristol-Myers Squibb?
The latest annual profit of Bristol-Myers Squibb is USD -8.95B
What is the registered address of Bristol-Myers Squibb?
The registered address for Bristol-Myers Squibb is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Bristol-Myers Squibb website address?
The website address for Bristol-Myers Squibb is www.bms.com
Which industry sector does Bristol-Myers Squibb operate in?
Bristol-Myers Squibb operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PATI3Panatlantica S.A.
R$ 27.00
(12.50%)
100
AMER3Americanas SA
R$ 6.84
(11.22%)
6.13M
AERI3Aeris Industria E ComerciodeEquipamentos paraGeracaodeEnergiaS.A
R$ 3.88
(6.59%)
773.4k
AMAR3Lojas Marisa S.A.
R$ 1.54
(5.48%)
533.6k
BHIA3Grupo Casas Bahia SA
R$ 5.02
(5.02%)
6.58M
LREN3QLojas Renner Sa
R$ 11.69
(-24.53%)
674.8k
JFEN3Joao Fortes Engenharia Sa
R$ 2.65
(-11.67%)
13.7k
PGMN3Empreendimentos Pague Menos S.A.
R$ 2.79
(-8.52%)
5.22M
BIED3Bioma Educacao S.A
R$ 3.16
(-8.14%)
200
PDGR3PDG Realty S.A. Empreendimentos E Participacoes
R$ 0.81
(-7.95%)
1.29M
COGN3CognaEducacao SA
R$ 1.67
(0.60%)
24.38M
HAPV3Hapvida Participacoes Investimento SA
R$ 2.06
(0.00%)
24.18M
MGLU3Magaz Luiza
R$ 8.36
(0.72%)
20.93M
ABEV3Ambev SA
R$ 12.82
(-1.99%)
14.37M
BBDC4Bco Bradesco Sa
R$ 11.39
(-1.04%)
14.3M

Discussion

View Full Feed
jay_tee jay_tee 4 minutes ago
Pump IT UP!! https://youtu.be/9EcjWd-O4jI?si=q0UEfxDHsm80scet/url] insert-text-here
RNVA
Rainer Rainer 4 minutes ago
off topic, the Trump truth social posts bashing Canada this morning are pretty nuts. Gotta be confusing for the Canadian Trumpers.
Imindog Imindog 4 minutes ago
Kenny don’t talk business to these ignorant nimrods it’s like beating your head against the wall wondering how can this many people be really this retarded honestly!! None of these guys know a damn thing about business or numbers or clearly they would know this is trailer trash
IQST
DiscoverGold DiscoverGold 5 minutes ago
S&P 500: While government shutdowns can create short-term volatility, historical data shows that the S&P 500 has gained an average of 12.7% in the 12 months after such events, with positive returns occurring 86.4% of the time
By: Isabelnet | March 11, 2025

• S&P 500
NeoSunTzu NeoSunTzu 5 minutes ago
Why did I get a sudden urge to eat a 😽 ... I'm not even Chinese 🥴🤣
BlazingStocks BlazingStocks 6 minutes ago
$COEP - Coeptis had previously held limited co-development rights to GEAR. As part of this exclusive GEAR license agreement with VyGen-Bio, Inc., Coeptis has formed a new majority-owned subsidiary, GEAR Therapeutics, Inc., with the mission to advance GEAR-based cell therapy towards human proof-of-co
COEP
manibiotech manibiotech 6 minutes ago
Answer to your looong post is , After more than a decade "show us the money "
NWBO
biotechinvestor1 biotechinvestor1 6 minutes ago
There used to be another permabear who went by the name easycomeandgo. His predictions and calls were so cconsistently bad, that nearly everytime he made one, it was a sure sign to take the opposite side. I miss him. He helped me buy the dips with surprising accuracy. 
HALO
al44 al44 6 minutes ago
Go gettem-



https://media.gettr.com/group4/getter/2025/03/11/11/7e8d1772-7f04-7aca-f63b-f36069542e6b/8115c24ee5d8aa8bb200a62f0ba26be2_768x0.jpg
TheHappyVulcan TheHappyVulcan 7 minutes ago
This company has a very reasonable value of 51 for an RSI, for the past three months accumulation is on the rise, float remains reasonable, debt load is minimal, no insider sales to speak of and they're in a favored tier for an OTC company.PPS has been rising steadily over the past month or so, too
MEDIF
ace65 ace65 7 minutes ago
Excellent i am holding ..been here awhile and GTSM has been trying to
keep it down forever it seems..i do believe we have a massive short.
VAYK
Ragnar Ragnar 7 minutes ago
Next leg up appears to be starting today.

$RITE
RITE
BCNstocks BCNstocks 7 minutes ago
Nice update out. Additionally, ADIA Nutrition’s CEO, Larry Powalisz, has promoted his longtime intern to aide, offloading key projects, marketing, and social media. This change allows leadership to focus on strategic expansion while maintaining our mission-driven approach.
ADIA
rainmaker71 rainmaker71 7 minutes ago
HUMMINGBIRD....THIS WEEK WOULD BE AN AMAZING TIME TO DROP SOME GOOD NEWS! PLEASE LET THE DOC KNOW
VDRM
DiscoverGold DiscoverGold 7 minutes ago
Silver $SLV - Bullish Tri-Candle Plot Update...
By: Sahara | March 11, 2025

• $SILVER $SLV - Bullish Tri-Candle Plot Update

Held over the Daily 12 & 20/MA's after B/Testing. Hope is here that W-3 of -iii (Blue) is under way....

pbs.twimg.com/
SILVER SLV
SkyLimit2022 SkyLimit2022 8 minutes ago
mani,

Thanks for reposting your insightful advisory. Sounds like you really hit the nail on the head 🔨

https://investorshub.advfn.com/uimage/uploads/2025/3/11/iwfamgiphy.gif

I believe that having a comprehensive IP patent portfolio, commercial li
NWBO
djjazzyjeff djjazzyjeff 9 minutes ago
They said in the shareholders letter they were going to start recruiting people for a phase 2 study in January. It is almost halfway through March and not a word. NOT GOOD
CYDY
againstallodds againstallodds 9 minutes ago
Phony Picasso painting PDIV AGAIN TODAY

MANIPULATION
PDIV
Ezzra Ezzra 9 minutes ago
Feels overdue for some news eh?
CETI
TrendTrade2016 TrendTrade2016 10 minutes ago
PCLA BOTTOM PLAY OFF 66C
PCLA
gfp927z gfp927z 10 minutes ago
Fwiw, I went to 5% with the stock allocation. Still not a large amount, but couldn't resist with the RSI under 30. Trump isn't showing any signs of backing down on the tariffs, but the market seems due for a bounce, albeit a temporary one.



https://m.media-amazon.com
Penny Stocks 2.0 Penny Stocks 2.0 10 minutes ago
Can't wait to steam roll .002, foolishness. Those shares will ne worth 5x minimum  soon..
VAYK